First Wave BioPharma Inc (FWBI) - Financial and Strategic SWOT Analysis Review

First Wave BioPharma Inc (FWBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.


The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

First Wave BioPharma Inc (First Wave BioPharma), formerly AzurRx BioPharma Inc, is a development-stage biopharmaceutical company that focuses on non-systemic biologics for the treatment of patients with gastrointestinal disorders. The company's products under development include MS1819 a non-systemic yeast recombinant enzyme intended for the treatment of exocrine pancreatic insufficiency exocrine (EPI) in patients with cystic fibrosis (CF) and chronic pancreatitis (CP). Its pre-clinical products include AZX1103 and AZX1101 which is a recombinant beta-lactamases enzyme for the prevention of nosocomial (hospital-acquired) infections and antibiotic-associated diarrhea. The company has operations in France and the US. First Wave BioPharma is headquartered in Brooklyn, New York, the US.

First Wave BioPharma Inc Key Recent Developments

Jan 30,2023: First Wave BioPharma to Present at the BIO CEO & Investor Conference
Jan 24,2023: First Wave BioPharma to present at Sequire Biotechnology Conference
Sep 28,2022: First Wave BioPharma’s CEO James Sapirstein to Present at Inaugural Roth Healthcare Opportunities Conference
Aug 29,2022: First Wave BioPharma to Present at H.C. Wainwright 24th Annual Global Investment Conference 2022

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note:Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
First Wave BioPharma Inc - Key Facts
First Wave BioPharma Inc - Key Employees
First Wave BioPharma Inc - Key Employee Biographies
First Wave BioPharma Inc - Major Products and Services
First Wave BioPharma Inc - History
First Wave BioPharma Inc - Company Statement
First Wave BioPharma Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
First Wave BioPharma Inc - Business Description
First Wave BioPharma Inc - SWOT Analysis
SWOT Analysis - Overview
First Wave BioPharma Inc - Strengths
First Wave BioPharma Inc - Weaknesses
First Wave BioPharma Inc - Opportunities
First Wave BioPharma Inc - Threats
First Wave BioPharma Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
First Wave BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
First Wave BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
First Wave BioPharma Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jan 30, 2023: First Wave BioPharma to Present at the BIO CEO & Investor Conference
Jan 24, 2023: First Wave BioPharma to present at Sequire Biotechnology Conference
Sep 28, 2022: First Wave BioPharma’s CEO James Sapirstein to Present at Inaugural Roth Healthcare Opportunities Conference
Aug 29, 2022: First Wave BioPharma to Present at H.C. Wainwright 24th Annual Global Investment Conference 2022
Apr 29, 2022: First Wave BioPharma Chairman and CEO Issues Letter to Shareholders
Apr 27, 2022: First Wave BioPharma forms clinical steering committee focused on advancing inflammatory bowel disease (IBD) product portfolio
Mar 22, 2022: First Wave BioPharma to Participate in Maxim’s 2022 Virtual Growth Conference
Mar 01, 2022: First Wave BioPharma Announces Appointment of Sarah Romano as Chief Financial Officer
Jan 07, 2022: First Wave BioPharma Announces Further Adjournment of Annual Meeting
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
First Wave BioPharma Inc, Key Facts
First Wave BioPharma Inc, Key Employees
First Wave BioPharma Inc, Key Employee Biographies
First Wave BioPharma Inc, Major Products and Services
First Wave BioPharma Inc, History
First Wave BioPharma Inc, Subsidiaries
First Wave BioPharma Inc, Key Competitors
First Wave BioPharma Inc, Ratios based on current share price
First Wave BioPharma Inc, Annual Ratios
First Wave BioPharma Inc, Annual Ratios (Cont...1)
First Wave BioPharma Inc, Interim Ratios
First Wave BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
First Wave BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
First Wave BioPharma Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
First Wave BioPharma Inc, Performance Chart (2018 - 2022)
First Wave BioPharma Inc, Ratio Charts
First Wave BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
First Wave BioPharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings